Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]

Detalles Bibliográficos
Autores principales: Zasadzka, Ewa, Pieczyńska, Anna, Trzmiel, Tomasz, Pawlaczyk, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Response to Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326395/
https://www.ncbi.nlm.nih.gov/pubmed/32616999
http://dx.doi.org/10.2147/CIA.S267802
_version_ 1783552332835848192
author Zasadzka, Ewa
Pieczyńska, Anna
Trzmiel, Tomasz
Pawlaczyk, Mariola
author_facet Zasadzka, Ewa
Pieczyńska, Anna
Trzmiel, Tomasz
Pawlaczyk, Mariola
author_sort Zasadzka, Ewa
collection PubMed
description
format Online
Article
Text
id pubmed-7326395
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73263952020-07-01 Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter] Zasadzka, Ewa Pieczyńska, Anna Trzmiel, Tomasz Pawlaczyk, Mariola Clin Interv Aging Response to Letter Dove 2020-06-25 /pmc/articles/PMC7326395/ /pubmed/32616999 http://dx.doi.org/10.2147/CIA.S267802 Text en © 2020 Zasadzka et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Response to Letter
Zasadzka, Ewa
Pieczyńska, Anna
Trzmiel, Tomasz
Pawlaczyk, Mariola
Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]
title Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]
title_full Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]
title_fullStr Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]
title_full_unstemmed Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]
title_short Important Points to Consider During Practical Application and in the Validation Studies of SARC-F Tool to Screen Sarcopenia [Response to Letter]
title_sort important points to consider during practical application and in the validation studies of sarc-f tool to screen sarcopenia [response to letter]
topic Response to Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326395/
https://www.ncbi.nlm.nih.gov/pubmed/32616999
http://dx.doi.org/10.2147/CIA.S267802
work_keys_str_mv AT zasadzkaewa importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter
AT pieczynskaanna importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter
AT trzmieltomasz importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter
AT pawlaczykmariola importantpointstoconsiderduringpracticalapplicationandinthevalidationstudiesofsarcftooltoscreensarcopeniaresponsetoletter

Ejemplares similares